Explore impactful case studies that highlight COTA’s innovative solutions in action. These stories illustrate the significant differences our data driven approach makes in patient care and healthcare improvement.
Much of today’s investigational cancer therapeutics originates in small biotechnology companies, most of which are innovative and agile by nature,
Much of today’s investigational cancer therapeutics originates in small biotechnology companies, most of which are innovative and agile by nature, but also lack the financial horsepower, resources, and infrastructure of…
Real-world data (RWD) in Oncology proves to be a vital source for clinical decisions and program decisions. COTA partnered with a Top 5 Pharma company to curate a custom multiple…
Despite advances in liquid biopsies, standard-of-care remains tissue-based genotyping, an approach that is relatively invasive, inconvenient, slow, and expensive
…
